Scarica l'app Stockscreener
120.58
3.79%
4.40
Pre-mercato:
120.44
-0.14
-0.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$116.18
Aprire:
$115.43
Volume 24 ore:
841.56K
Relative Volume:
1.07
Capitalizzazione di mercato:
$6.78B
Reddito:
$633.51M
Utile/perdita netta:
$-8.10M
Rapporto P/E:
-388.97
EPS:
-0.31
Flusso di cassa netto:
$131.26M
1 W Prestazione:
-1.30%
1M Prestazione:
+3.50%
6M Prestazione:
-22.11%
1 anno Prestazione:
-16.54%
Intervallo 1D:
$112.71
$120.67
Intervallo di 1 settimana:
$112.71
$124.91
Portata 52W:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Confronta RGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
120.58 | 6.79B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
454.52 | 168.15B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
191.26 | 53.93B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.81 | 39.68B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.91 | 38.70B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
247.54 | 17.53B | 2.96B | 487.70M | 344.00M | 6.68 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
Why Repligen Corporation is moving today2025 Year in Review & Fast Gain Stock Trading Tips - Newser
Repligen at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com
Visual trend scoring systems applied to Repligen Corporation2025 Market Trends & Technical Buy Zone Confirmation - Newser
What is Repligen Corporation s P E ratio telling usInflation Watch & High Conviction Buy Zone Alerts - khodrobank.com
What is Repligen Corporation s debt to equity ratioJuly 2025 Fed Impact & Capital Protection Trade Alerts - khodrobank.com
Risk adjusted return profile for Repligen Corporation analyzedJuly 2025 Trends & Community Consensus Picks - Newser
What recovery options are there for Repligen CorporationJuly 2025 Breakouts & Reliable Price Breakout Alerts - Newser
Understanding Repligen Corporation’s price movementWeekly Stock Report & Safe Capital Growth Trade Ideas - Newser
Is Repligen Corporation building a consolidation baseJuly 2025 Action & Weekly Breakout Watchlists - Newser
Repligen stock rating reiterated at Buy by H.C. Wainwright - Investing.com
Should you wait for a breakout in Repligen CorporationProfit Target & Fast Gaining Stock Strategy Reports - Newser
Custom watchlist performance reports with Repligen CorporationJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Will Repligen Corporation outperform tech stocks2025 Momentum Check & Free High Accuracy Swing Entry Alerts - khodrobank.com
Repligen Corporation stock daily chart insights2025 Support & Resistance & Daily Profit Maximizing Trade Tips - Newser
Repligen appoints Violetta Hughes as chief accounting officer effective September 1 - Investing.com
Statistical indicators supporting Repligen Corporation’s strengthJuly 2025 Recap & Community Verified Trade Signals - Newser
What’s the outlook for Repligen Corporation’s sectorWeekly Trading Summary & Intraday High Probability Setup Alerts - khodrobank.com
What the charts say about Repligen Corporation todayPortfolio Risk Report & Entry Point Confirmation Alerts - Newser
Can Repligen Corporation maintain its current growth rate2025 Institutional Moves & Safe Capital Growth Trade Ideas - khodrobank.com
What are Repligen Corporation’s earnings expectations2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - khodrobank.com
Will Repligen Corporation price bounce be sustainableLayoff News & Weekly Top Stock Performers List - Newser
How to monitor Repligen Corporation with trend dashboards2025 Pullback Review & Expert Approved Momentum Ideas - Newser
Using RSI to spot recovery in Repligen CorporationWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Will Repligen Corporation benefit from macro trendsJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Institutional scanner results for Repligen CorporationJuly 2025 Action & Weekly Top Stock Performers List - Newser
Strategies to average down on Repligen CorporationEarnings Recap Summary & Daily Stock Trend Watchlist - Newser
Applying Elliott Wave Theory to Repligen Corporation2025 Major Catalysts & Fast Entry and Exit Trade Plans - Newser
How Repligen Corporation stock performs during market volatility2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - Newser
Evaluating Repligen Corporation with trendline analysisTrade Analysis Report & Growth Oriented Trade Recommendations - Newser
Analyzing recovery setups for Repligen Corporation investorsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
What’s next for Repligen Corporation stock price2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
Using fundamentals and technicals on Repligen Corporation2025 Price Momentum & Weekly Setup with ROI Potential - Newser
Long term hold vs stop loss in Repligen CorporationJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Building trade automation scripts for Repligen CorporationWeekly Profit Recap & Fast Moving Stock Trade Plans - Newser
Has Repligen Corporation found a price floor2025 Fundamental Recap & AI Based Buy and Sell Signals - Newser
Repligen Corporation stock momentum explainedQuarterly Profit Report & AI Enhanced Market Trend Forecasts - Newser
Repligen Corporation stock prediction for this weekMarket Sentiment Report & Daily Momentum Trading Reports - Newser
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Repligen Corp Azioni (RGEN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
May 15 '25 |
Sale |
123.71 |
26,447 |
3,271,688 |
109,854 |
1.77%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):